Literature DB >> 16488703

Genetic syndromes and outcome after surgical correction of tetralogy of Fallot.

Guido Michielon1, Bruno Marino, Roberto Formigari, Gaetano Gargiulo, Fernando Picchio, Maria C Digilio, Silvia Anaclerio, Gianluca Oricchio, Stephen P Sanders, Roberto M Di Donato.   

Abstract

BACKGROUND: Genetic syndromes occur in 20% of patients with tetralogy of Fallot (TOF). The impact of genetic syndromes on surgical repair of TOF in infancy is still under investigation.
METHODS: This retrospective study reviews the outcome of 306 consecutive patients (median age, 5.1 months) who underwent primary (266) or staged (40) repair of TOF between 1994 and 2004. Total follow-up was 1,188 patient-years (mean, 57 months).
RESULTS: Genetic syndromes were documented in 85 patients (27.8%), including 22q11 deletion (27), trisomy 21 (13), vertebral, anal, cardiac, tracheoesophageal, renal, and limb abnormalities (VACTERL, 12), and others (33). Hypoplastic pulmonary arteries (PA) were more common in syndromic (19/85 = 22.3%) than nonsyndromic TOF (20/221 = 9.04%) (p < 0.001). Primary repair was performed in 82.4% syndromic and 88.7% nonsyndromic TOF (p = not significant [NS]). Ten-year actuarial survival was 94.1 +/- 2.3% in nonsyndromic and 84.3 +/-4.2% in syndromic TOF (p < 0.001). Ten-year survival was 96.3 +/- 3.6% for del22q11, 100% for trisomy 21, 63.6 +/- 14.5% for VACTERL, and 78.5 +/- 7.3% for patients with other syndromes (p = 0.022). Survival in syndromic TOF with normal PA anatomy was 89.6 +/- 4.2% for primary repair and 85.7 +/- 12.8% for staged repair (p = NS); freedom from reoperation after complete repair was 74.4 +/- 6.4% for primary correction and 56.3 +/- 11.9% for staged repair (p = 0.04). Cox proportional hazard identified the presence of genetic syndrome (p = 0.011) and central PA hypoplasia (p = 0.002) as independent predictors of mortality.
CONCLUSIONS: Pulmonary arborization defects and genetic syndromes other than del22q11 or trisomy 21, are associated with worse outcome after correction of TOF. Primary TOF repair in syndromic patients with normal PA anatomy is a valid surgical strategy, with no additional risk for mortality and higher freedom from reintervention.

Entities:  

Mesh:

Year:  2006        PMID: 16488703     DOI: 10.1016/j.athoracsur.2005.09.033

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  26 in total

Review 1.  13q13.1-q13.2 deletion in tetralogy of Fallot: clinical report and a literature review.

Authors:  Gregory Costain; Candice K Silversides; Christian R Marshall; Mary Shago; Nicholas Costain; Anne S Bassett
Journal:  Int J Cardiol       Date:  2010-07-03       Impact factor: 4.164

Review 2.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

Review 3.  Congenital diaphragmatic hernia and associated cardiovascular malformations: type, frequency, and impact on management.

Authors:  Angela E Lin; Barbara R Pober; Ian Adatia
Journal:  Am J Med Genet C Semin Med Genet       Date:  2007-05-15       Impact factor: 3.908

4.  Premature death in adults with 22q11.2 deletion syndrome.

Authors:  A S Bassett; E W C Chow; J Husted; K A Hodgkinson; E Oechslin; L Harris; C Silversides
Journal:  J Med Genet       Date:  2009-02-25       Impact factor: 6.318

5.  22q11.2 deletion status and disease burden in children and adolescents with tetralogy of Fallot.

Authors:  Laura Mercer-Rosa; Stephen M Paridon; Mark A Fogel; Jack Rychik; Ronn E Tanel; Huaqing Zhao; Xuemei Zhang; Wei Yang; Justine Shults; Elizabeth Goldmuntz
Journal:  Circ Cardiovasc Genet       Date:  2015-01-05

6.  Influence of chromosome 22q11.2 microdeletion on postoperative calcium level after cardiac-correction surgery.

Authors:  Li Shen; Haitao Gu; Dongjing Wang; Chi Yang; Zhengfeng Xu; Hua Jing; Yongzhong Jiang; Yibing Ding; Huacheng Hou; Zhijuan Ge; Shilin Chen; Xuming Mo; Long Yi
Journal:  Pediatr Cardiol       Date:  2011-06-16       Impact factor: 1.655

7.  Clinical course and outcome predictors of critically ill infants with complete DiGeorge anomaly following thymus transplantation.

Authors:  Jan Hau Lee; M Louise Markert; Christoph P Hornik; Elizabeth A McCarthy; Stephanie E Gupton; Ira M Cheifetz; David A Turner
Journal:  Pediatr Crit Care Med       Date:  2014-09       Impact factor: 3.624

8.  Identification of differently expressed genes and small molecule drugs for Tetralogy of Fallot by bioinformatics strategy.

Authors:  Qiang Gu; Xue-Tao Chen; Ying-Bin Xiao; Lin Chen; Xue-Feng Wang; Jun Fang; Bai-Cheng Chen; Jia Hao
Journal:  Pediatr Cardiol       Date:  2014-01-25       Impact factor: 1.655

9.  Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.

Authors:  P Eberle; C Berger; S Junge; S Dougoud; E Valsangiacomo Büchel; M Riegel; A Schinzel; R Seger; T Güngör
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

Review 10.  Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management.

Authors:  Angela E Lin; Craig T Basson; Elizabeth Goldmuntz; Pilar L Magoulas; Deborah A McDermott; Donna M McDonald-McGinn; Elspeth McPherson; Colleen A Morris; Jacqueline Noonan; Catherine Nowak; Mary Ella Pierpont; Reed E Pyeritz; Alan F Rope; Elaine Zackai; Barbara R Pober
Journal:  Genet Med       Date:  2008-07       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.